Hepatitis B and C Viruses as Risk Factors for Liver Cancer
Author Information
Author(s): JF Tsai, JE Jeng, MS Ho, WY Chang, MY Hsieh, ZY Lin, JH Tsai
Primary Institution: Kaohsiung Medical College, Taiwan
Hypothesis
The study aims to assess the role of hepatitis B e antigen (HBeAg) and its interaction with hepatitis B surface antigen (HBsAg) on the development of hepatocellular carcinoma (HCC).
Conclusion
HBsAg, HBeAg, and anti-HCV are independent risk factors for HCC, with an additive effect between HBsAg and HBeAg.
Supporting Evidence
- The prevalence of HBeAg, HBsAg, and anti-HCV in HCC patients was significantly higher than in healthy controls.
- Multivariate analysis indicated that both HBsAg and HBeAg are independent risk factors for HCC.
- Patients with both HBsAg and HBeAg had the highest odds ratio for developing HCC.
Takeaway
This study found that people with certain hepatitis infections are more likely to develop liver cancer, especially if they have both types of hepatitis B markers.
Methodology
A case-control study comparing 361 patients with HCC to 361 healthy controls matched by age and sex.
Limitations
The study is retrospective, which may affect the reliability of the findings.
Participant Demographics
The study included 303 men and 58 women with a mean age of 53 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI, 2.4-27.1 for HBeAg; 95% CI, 20.5-227.8 for HBsAg; 95% CI, 13.6-258.4 for anti-HCV
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website